SmartCella Holding AB Revenue and Competitors
Estimated Revenue & Valuation
- SmartCella Holding AB's estimated annual revenue is currently $12.1M per year.
- SmartCella Holding AB's estimated revenue per employee is $155,000
Employee Data
- SmartCella Holding AB has 78 Employees.
- SmartCella Holding AB grew their employee count by 24% last year.
SmartCella Holding AB's People
Name | Title | Email/Phone |
---|---|---|
1 | COO | Reveal Email/Phone |
2 | Chief Technology Officer | Reveal Email/Phone |
3 | Head Accounting | Reveal Email/Phone |
4 | Head Quality, VP | Reveal Email/Phone |
5 | Director Business Development | Reveal Email/Phone |
6 | Office Manager | Reveal Email/Phone |
7 | QA Manager | Reveal Email/Phone |
8 | Senior Quality Assurance Manager | Reveal Email/Phone |
9 | Supply Chain Manager | Reveal Email/Phone |
10 | Laboratory Manager | Reveal Email/Phone |
SmartCella Holding AB Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $11.8M | 76 | 17% | N/A | N/A |
#2 | $12.1M | 78 | 24% | N/A | N/A |
#3 | $5M | 32 | 23% | $39.4M | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $2.5M | 16 | 33% | $6.7M | N/A |
#7 | $3.1M | 20 | 18% | $12.3M | N/A |
What Is SmartCella Holding AB?
SmartCella is a global biotech company pioneering the future of targeted therapies through delivery solutions and advanced therapy development. Founded in 2014, the company is built on globally renowned science and research from Karolinska Institutet in Sweden.\n\nSmartCella combines novel delivery platforms, such as the Extroducer® (an endovascular delivery device that enables direct injection to hard-to-reach organs and tumors), with state-of-the-art development and manufacturing of stem cell-based therapies. The company operates in two business segments: Targeted Deliveries and Regenerative Medicines.\n\nThe international team consists of scientists, visionary innovators, and experienced business leaders, all dedicated to shaping the future of targeted therapies and delivering life-changing treatments to patients.
keywords:N/AN/A
Total Funding
78
Number of Employees
$12.1M
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $30.4M | 121 | -1% | N/A |